315 related articles for article (PubMed ID: 34135415)
1. Pharmacologic modulation of 5-fluorouracil by folinic acid and high-dose pyridoxine for treatment of patients with digestive tract carcinomas.
Machover D; Almohamad W; Castagné V; Desterke C; Gomez L; Gaston-Mathé Y; Boucheix C; Goldschmidt E
Sci Rep; 2021 Jun; 11(1):12668. PubMed ID: 34135415
[TBL] [Abstract][Full Text] [Related]
2. Pharmacologic modulation of 5-fluorouracil by folinic acid and pyridoxine for treatment of patients with advanced breast carcinoma.
Machover D; Goldschmidt E; Almohamad W; Castagné V; Dairou J; Desterke C; Gomez L; Gaston-Mathé Y; Boucheix C
Sci Rep; 2022 May; 12(1):9079. PubMed ID: 35641554
[TBL] [Abstract][Full Text] [Related]
3. Treatment of advanced colorectal and gastric adenocarcinomas with 5-fluorouracil and high-dose folinic acid.
Machover D; Goldschmidt E; Chollet P; Metzger G; Zittoun J; Benavides M; Marquet J; Vandenbulcke JM; Misset JL; Schwarzenberg L
NCI Monogr; 1987; (5):193-8. PubMed ID: 3501542
[TBL] [Abstract][Full Text] [Related]
4. A randomized study of bolus fluorouracil plus folinic acid versus 21-day fluorouracil infusion alone or in association with cyclophosphamide and mitomycin C in advanced colorectal carcinoma.
Caudry M; Bonnel C; Floquet A; Marsault C; Quétin P; Pujol J; Maton O; Dujols JP; Caudry Y; Skawinski P
Am J Clin Oncol; 1995 Apr; 18(2):118-25. PubMed ID: 7900703
[TBL] [Abstract][Full Text] [Related]
5. High-dose folinic acid and 5-fluorouracil in the treatment of advanced colon cancer.
Scholnik AP; Arnold DJ; Walker WS; Schwenke P; Suhrland LG; Balcueva EP; Dimitrov NV
Am J Clin Oncol; 1988 Oct; 11(5):558-63. PubMed ID: 3263037
[TBL] [Abstract][Full Text] [Related]
6. Biochemical modulation of fluorouracil: comparison of methotrexate, folinic acid, and fluorouracil versus folinic acid and fluorouracil in advanced colorectal cancer: a randomized trial.
Polyzos A; Tsavaris N; Giannopoulos A; Bacoyiannis C; Papadimas V; Kalahanis N; Karatzas G; Kosmas C; Sakelaropoulos N; Archimandritis A; Papachristodoulou A; Kosmidis P
Cancer Chemother Pharmacol; 1996; 38(3):292-7. PubMed ID: 8646806
[TBL] [Abstract][Full Text] [Related]
7. Weekly High-dose 5-Fluorouracil as 24-hour Infusion Combined with Sodium Folinic Acid (AIO regimen) Plus Irinotecan in Second-line and Sequential Therapy of Metastatic Colorectal Cancer (CRC).
Wein A; Siebler J; Wolff K; Ostermeier N; Busse D; Hagel A; Koch F; Merx K; Neurath MF; Hofheinz RD
Anticancer Res; 2017 Jul; 37(7):3771-3779. PubMed ID: 28668873
[TBL] [Abstract][Full Text] [Related]
8. Second-line chemotherapy with weekly oxaliplatin and high-dose 5-fluorouracil with folinic acid in metastatic colorectal carcinoma: a Hellenic Cooperative Oncology Group (HeCOG) phase II feasibility study.
Janinis J; Papakostas P; Samelis G; Skarlos D; Papagianopoulos P; Fountzilas G
Ann Oncol; 2000 Feb; 11(2):163-7. PubMed ID: 10761750
[TBL] [Abstract][Full Text] [Related]
9. Enhancement of 5-Fluorouracil Cytotoxicity by Pyridoxal 5'-Phosphate and Folinic Acid in Tandem.
Machover D; Goldschmidt E; Mollicone R; Haghighi-Rad F; Desterke C; Gaston-Mathé Y; Saffroy R; Boucheix C; Dairou J
J Pharmacol Exp Ther; 2018 Aug; 366(2):238-243. PubMed ID: 29858389
[TBL] [Abstract][Full Text] [Related]
10. Double modulation of 5-fluorouracil with interferon alpha 2a and high-dose leucovorin: a phase I and II study.
Seymour MT; Johnson PW; Hall MR; Wrigley PF; Slevin ML
Br J Cancer; 1994 Oct; 70(4):719-23. PubMed ID: 7917927
[TBL] [Abstract][Full Text] [Related]
11. Dramatic tumor response of bulky liver metastases following treatment with CPT-11 and a chronomodulated 4-day infusion of 5-fluorouracil, folinic acid and oxaliplatin every 2 weeks in a colorectal cancer patient.
Gornet JM; Azoulay D; Lévi F; Yovine A; Misset JL; Goldwasser F
Anticancer Drugs; 2000 Apr; 11(4):263-8. PubMed ID: 10898541
[TBL] [Abstract][Full Text] [Related]
12. Randomized phase II study of sequential docetaxel and irinotecan with 5-fluorouracil/folinic acid (leucovorin) in patients with advanced gastric cancer: the GATAC trial.
Gubanski M; Johnsson A; Fernebro E; Kadar L; Karlberg I; Flygare P; Berglund A; Glimelius B; Lind PA;
Gastric Cancer; 2010 Aug; 13(3):155-61. PubMed ID: 20820984
[TBL] [Abstract][Full Text] [Related]
13. Alternating bolus and continuous infusion 5-fluorouracil: a strategy to overcome resistance to this fluoropyrimidine in advanced colorectal cancer patients.
Guglielmi A; Aschele C; Grossi F; Tixi L; Sobrero A
Cytotechnology; 1996; 19(3):215-9. PubMed ID: 8862009
[TBL] [Abstract][Full Text] [Related]
14. Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy.
Nobili S; Checcacci D; Filippelli F; Del Buono S; Mazzocchi V; Mazzei T; Mini E
J Chemother; 2008 Oct; 20(5):622-31. PubMed ID: 19028627
[TBL] [Abstract][Full Text] [Related]
15. 5-Fluorouracil, high-dose folinic acid, and mitomycin C combination chemotherapy in advanced gastrointestinal adenocarcinomas. A pilot study.
Becouarn Y; Brunet R; Bussières E; Marée D
Oncology; 1988; 45(4):269-72. PubMed ID: 3133620
[TBL] [Abstract][Full Text] [Related]
16. 5-Fluorouracil combined with the [6S]-stereoisomer of folinic acid in high doses for treatment of patients with advanced colorectal carcinoma. A phase I-II study of two consecutive regimens.
Machover D; Grison X; Goldschmidt E; Zittoun J; Metzger G; Richaud J; Lotz JP; André T; Hannoun L; Marquet J
Ann Oncol; 1993; 4 Suppl 2():29-35. PubMed ID: 8353102
[TBL] [Abstract][Full Text] [Related]
17. Bevacizumab plus infusional 5-fluorouracil, leucovorin and irinotecan for advanced colorectal cancer that progressed after oxaliplatin and irinotecan chemotherapy: a pilot study.
Kwon HC; Oh SY; Lee S; Kim SH; Kim HJ
World J Gastroenterol; 2007 Dec; 13(46):6231-5. PubMed ID: 18069765
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the Fas signaling pathway by IFN-gamma in therapy of colon cancer: phase I trial and correlative studies of IFN-gamma, 5-fluorouracil, and leucovorin.
Schwartzberg LS; Petak I; Stewart C; Turner PK; Ashley J; Tillman DM; Douglas L; Tan M; Billups C; Mihalik R; Weir A; Tauer K; Shope S; Houghton JA
Clin Cancer Res; 2002 Aug; 8(8):2488-98. PubMed ID: 12171874
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy: How useful is adjuvant irinotecan in stage IV CRC?
Loupakis F; Falcone A
Nat Rev Clin Oncol; 2010 Apr; 7(4):190-1. PubMed ID: 20354542
[TBL] [Abstract][Full Text] [Related]
20. Clinical studies of biochemical modulation of 5-fluorouracil by leucovorin in patients with advanced colorectal cancer by the North Central Cancer Treatment Group and Mayo Clinic.
O'Connell MJ; Klaassen DJ; Everson LK; Cullinan S; Wieand HS
NCI Monogr; 1987; (5):185-8. PubMed ID: 3501540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
